Expert Interview
Discussing the potential of tirzepatide in patients with obesity and the recent results from the Phase 3 SURMOUNT 3 and 4 studies in adults with obesity
Ticker(s): LLY
Institution: Ameet Kumar MD LLC
- board certified Internal Medicine Physician
- treats 300-400 per month with obesity
- familiar with the results from the Phase 3 SURMOUNT 3 and SURMOUNT 4 studies in adults with obesity
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
